GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (STU:N2U0) » Definitions » EV-to-Revenue

Adlai Nortye (STU:N2U0) EV-to-Revenue : (As of May. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Adlai Nortye's enterprise value is €214.86 Mil. Adlai Nortye's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00 Mil. Therefore, Adlai Nortye's EV-to-Revenue for today is .

The historical rank and industry rank for Adlai Nortye's EV-to-Revenue or its related term are showing as below:

STU:N2U0' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 43.44

STU:N2U0's EV-to-Revenue is ranked worse than
77.49% of 1035 companies
in the Biotechnology industry
Industry Median: 7.82 vs STU:N2U0: 43.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-31), Adlai Nortye's stock price is €6.80. Adlai Nortye's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00. Therefore, Adlai Nortye's PS Ratio for today is .


Adlai Nortye EV-to-Revenue Historical Data

The historical data trend for Adlai Nortye's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye EV-to-Revenue Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
EV-to-Revenue
- - 47.37

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Adlai Nortye's EV-to-Revenue

For the Biotechnology subindustry, Adlai Nortye's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adlai Nortye's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's EV-to-Revenue falls into.



Adlai Nortye EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Adlai Nortye's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=214.860/0
=

Adlai Nortye's current Enterprise Value is €214.86 Mil.
Adlai Nortye's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adlai Nortye  (STU:N2U0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Adlai Nortye's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.80/0
=

Adlai Nortye's share price for today is €6.80.
Adlai Nortye's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adlai Nortye EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Adlai Nortye (STU:N2U0) Business Description

Traded in Other Exchanges
Address
685 US Highway 1, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. The company has robust pipeline of drug candidates it includes buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as four preclinical candidates.

Adlai Nortye (STU:N2U0) Headlines

No Headlines